查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475009

硫酸麻黃鹼市場：依純度、給藥方式、依適應症、依地區、機會、預測，2017-2031年

Ephedrine Sulfate Market Assessment, By Purity, By Mode of Administration, By Disease Indication, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 230 Pages | 商品交期: 3-5個工作天內

價格

2024-2031年預測期間，全球硫酸麻黃鹼市場規模將以6.1%的複合年增長率擴大，從2023年的1.2245億美元增長到2031年的1.9664億美元。 支持市場成長的是脊髓麻醉引起的低血壓盛行率上升和支氣管氣喘病例的增加。

支氣管氣喘盛行率上升是全球硫酸麻黃鹼市場的一個主要趨勢。 支氣管氣喘是一種慢性發炎性疾病，以不同程度的氣道阻塞和支氣管過度活躍為特徵。 支氣管氣喘的診斷是基於肺功能測試、身體檢查和化學史，包括支氣管活動測量和可逆性測試。 例如，澳洲統計局估計，到 2022 年，將有不到 280 萬人患有氣喘。 由於氣喘患者數量不斷增加，硫酸麻黃鹼的需求量迅速增加。 麻黃鹼可作為祛痰劑和支氣管擴張劑，擴大氣道，使輕度氣喘患者更容易呼吸。 因此，產品需求不斷增加，推動了各地區的市場成長。

椎管內麻醉期間低血壓發生率的增加是推動全球硫酸麻黃鹼市場需求的關鍵因素之一。 例如，2021 年發表的一項前瞻性觀察研究表明，剖腹產期間使用脊髓麻醉的病例中有 76% 出現低血壓。 麻黃鹼用於控制和治療臨床上顯著的低血壓，是脊髓和硬膜外麻醉引起的低血壓的首選藥物。 麻黃鹼推注可有效預防剖腹產患者脊髓引起的低血壓。 因此，對硫酸麻黃鹼的需求增加並確保了調節症狀所必需的藥物的生產，從而推動了市場成長。

本報告考察了全球硫酸麻黃鹼市場，並提供了市場概況，包括純度趨勢、給藥方式、適應症、區域趨勢以及參與市場的公司概況。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第 4 章顧客回饋

第五章2017-2031 年全球麻黃鹼硫酸鹽市場展望

  • 市場規模與預測
  • 依純度
  • 依管理方式
  • 依疾病適應症
  • 依地區
  • 各公司的市佔率 (%)，2023 年

第 6 章 2017-2031 年全球硫酸麻黃鹼市場展望（依地區）

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第七章供給面分析

第 8 章市場地圖，2023 年

第九章宏觀環境與產業結構

  • 供應需求分析
  • 進出口分析
  • 供應鏈分析
  • PESTEL 分析
  • 波特五力分析

第 10 章市場動態

第十一章 主要與會企業狀況

第十二章價格分析

第 13 章案例研究

第 14 章主要進入者展望

  • Spectrum Chemical Mfg. Corp.
  • Taj Pharmaceutical Limited
  • Sigma- Aldrich (Merck KGaA)
  • Biosynth
  • Midas Pharma
  • Malladi Drugs & Pharmaceuticals Ltd.
  • Embio Limited
  • Siegfried Holding AG
  • Nortec Quimica S.A.
  • Cymit Quimica S.L.

第 15 章策略建議

第十六章查詢及免責聲明

Product Code: MX11276

Global ephedrine sulfate market is projected to witness a CAGR of 6.1% during the forecast period 2024-2031, growing from USD 122.45 million in 2023 to USD 196.64 million in 2031F. The market growth is supported by the increasing prevalence of spinal anesthesia-induced hypotension and rising cases of bronchial asthma.

The increasing prevalence of bronchial asthma is a leading global ephedrine sulfate market trend. Bronchial asthma, a chronic inflammatory disease, is characterized by variable degrees of airway obstruction and bronchial hyperactivity. The condition is diagnosed based on pulmonary test functions, including measurement of bronchial activity and reversibility testing, physical examination, and chemical history. For instance, the Australian Bureau of Statistics estimates that under 2.8 million individuals were asthmatic in 2022. Due to the rise in the number of cases of asthma, the requirement for ephedrine sulfate is witnessing a rapid increase as ephedrine works as an expectorant and bronchodilator, opening the air passages and allowing individuals with mild asthma to breathe more easily. Thus, boosting the product demand and supporting market growth in various regions.

Moreover, the rapid expansion of the pharmaceutical sector in various regions across the globe is further bolstering the growth of the market. For instance, according to Invest India, the Indian pharmaceutical industry is expected to reach USD 130 billion by 2030. The growth propels the requirement of ephedrine sulfate as this beta and alpha-adrenergic agonist can enhance the release of norepinephrine. The chemical has been used for urinary incontinence, heart failure, and rhinitis and is deployed for treating depression and narcolepsy, because of the central nervous system stimulatory effects that it offers. Due to the advantages and applications offered by the product, it is increasingly being used by the pharmaceutical sector, thus augmenting market expansion.

Increase in Incidences of Hypotension During Provision of Spinal Anesthesia

The rising incidences of hypotension during the provision of spinal anesthesia are one of the major factors boosting the global ephedrine sulfate market demand. For instance, a prospective observational study published in 2021 showed that hypotension was reported in 76% of the cases where spinal anesthesia was provided during cesarean section. Ephedrine is used for managing and treating clinically significant hypotension and is the agent of choice for spinal or epidural anesthesia induced hypotension. Ephedrine administered as bolus dose is efficacious in preventing spinal-induced hypotension in patients that are undergoing cesarean section. Thus, bolstering the demand for ephedrine sulfate to ensure the manufacturing of the drugs essential for regulating the condition and propelling the growth of the market.

Expansion of Pharmaceutical Sector Will Boost the Global Ephedrine Sulfate Market Growth

The rapid expansion of the pharmaceutical sector in the region will provide lucrative growth opportunities for the market over the forecast period. For instance, the Association of the British Pharmaceutical Industry estimates that the pharmaceutical industry in the United Kingdom has a turnover of USD 51.7 billion (GBP 40.8 billion). Due to this rapid expansion of the pharmaceutical industry, the demand for ephedrine sulfate is increasing as the product finds various applications in the pharmaceutical sector. Ephedrine belongs to the sympathomimetic class of drugs and is used for treating and managing clinically significant hypotension. Also, the chemical is approved for treating hypotension secondary to spinal anesthesia and reversible bronchospasm and bronchial asthma. Thus, augmenting the product demand from the pharmaceutical sector.

North America Holds Significant Market Share

The expansion of the pharmaceutical sector, increase in number of cases of asthma, and growing emphasis on research and development activities are some of the major factors supporting the growth of North America ephedrine sulfate market. For instance, the Asthma and Allergy Foundation of America estimates that in 2022, approximately 1 in 13 people in the United States, approximately 26 million people, had asthma. The increase is boosting the requirement for ephedrine sulfate as for treating asthma, every four hours, 25 mg tablets of ephedrine sulfate are required, while the maximum dose should not exceed 150 mg in 24 hours. For adults, the intramuscular doses for prolonged desired effects are 25-50 mg and dose recommendations for bolus are 5-10 mg. Thus, augmenting the demand for ephedrine sulfate in the region.

Additionally, the increasing provision of approval by the US Food and Drug Administration (FDA) for treating hypotension in anesthesia settings with ephedrine sulfate injections is further aiding the growth of the market in North America. For instance, in March 2023, Nexus Pharmaceuticals, Inc. announced they received approval from the FDA for EMERPHED. The pre-filled single-dose syringes are available in 50mg/10mL and 25mg/5mL. The provision of such approvals by the FDA, therefore, provides lucrative growth opportunities to the market.

Above 99% Pure Ephedrine Sulfate to Account for Significant Market Share

The rising requirement for ephedrine sulfate, which has above 99% purity, can be attributed to various applications offered by chemicals in the pharmaceutical sector. Ephedrine increases blood pressure by stimulating cardiac output and heart rate and variably augmenting peripheral resistance. It causes bronchodilation due to the activation of beta-adrenergic receptors present in the lungs. The therapeutic window of ephedrine is large, as patients can receive doses from 5mg to 50 mg. The increasing requirement for ephedrine sulfate injections to treat and manage clinically important hypotension induced by anesthesia further supports the segment's expansion.

Moreover, the rapid expansion of the pharmaceutical sector in various regions across the globe is further propelling the requirement for ephedrine sulfate with above 99% purity. For instance, in 2021, 49.1% of global pharmaceutical sales were accounted for by North America, and approximately 23.4% were accounted for by Europe. Due to the increase in sales of pharmaceutical products, the requirement for ephedrine sulfate with above 99% purity is augmenting as the chemical finds applications in various drugs. Thus, propelling the growth of the segment and boosting the market demand.

Increasing Prevalence of Bronchial Asthma Boosts Global Ephedrine Sulfate Market Size

The rise in the number of individuals suffering from bronchial asthma provides lucrative growth opportunities for the market. For instance, the American College of Allergy, Asthma and Immunology estimates that approximately 7.7% of Americans, or 24.9 million people, had asthma in 2023; of these, approximately 4.6 million are children, and 20.2 million are adults. The increase in the number of cases of asthma is thus propelling the requirement for ephedrine sulfate as the beta and alpha-adrenergic agonist is used for relieving acute bronchospasm. Ephedrine sulfate oral tablets are indicated for providing temporary relief against the mild symptoms of intermittent asthma, such as shortness of breath, episodic wheezing, and tightness of the chest. Due to such advantages, the demand for ephedrine sulfate tablets is rising in managing asthma symptoms and enhancing patient comfort. Thus, augmenting the requirement for ephedrine sulfate for manufacturing the tablets to meet the growing demand of the patients and propelling the market expansion.

Future Market Scenario (2024 - 2031F)

According to global ephedrine sulfate market analysis, the increase in research and development activities to test the efficacy of treatment solutions derived from ephedrine sulfate will boost the expansion of the market over the forecast period. For instance, KK Women's and Children's Hospital, based in Singapore, is conducting an interventional study to develop a novel algorithm for an advanced DIVA (ADIVA) system for rigorously controlling blood pressure by detecting blood pressure with a stable hemodynamic profile. The automated delivery system will administer ephedrine and phenylephrine via a three-step algorithm vasopressor technique. When the systolic blood pressure is between 90-110% of baseline, 2mg of ephedrine will be given either in bolus or infusion if the heart rate less than 60 beats/ min. In the situation where the systolic blood pressure is less than 90% of the baseline 2-6 mg of ephedrine will be given either in bolus or infusion if the heart rate less than 60 beats/ min. The experiment is expected to conclude in December 2024. Such studies will aid in evaluating the functioning of drugs derived from ephedrine sulfate, propelling the demand for the product, and boosting the global ephedrine sulfate market growth.

Key Players Landscape and Outlook

The increasing provision of approval by the various regulatory bodies for the usage of ephedrine sulfate injections, among others, is supporting the expansion of market players. For instance, in 2023, Zydus Lifesciences Limited, received approval from the USFDA for ephedrine sulfate injections. These injections are indicated for treating hypotension occurring due to anesthesia. The company received approval from the regulatory body to market and manufacture ephedrine sulfate injection USP, 50 mg/ mL single-dose vials. Such approvals are propelling the requirement for ephedrine sulfate and providing lucrative growth opportunities to the market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Ephedrine Sulfate Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Purity
    • 5.2.1.Less than 98%
    • 5.2.2.98% to 99%
    • 5.2.3.Above 99%
  • 5.3.By Mode of Administration
    • 5.3.1.Intravenous Injections
    • 5.3.2.Nasal Spray
  • 5.4.By Disease Indication
    • 5.4.1.Spinal Anesthesia-Induced Hypotension
    • 5.4.2.Nasal Congestion
    • 5.4.3.Bronchial Asthma
    • 5.4.4.Others
  • 5.5.By Region
    • 5.5.1.North America
    • 5.5.2.South America
    • 5.5.3.Europe
    • 5.5.4.Asia-Pacific
    • 5.5.5.Middle East & Africa
  • 5.6.By Company Market Share (%), 2023

6.Global Ephedrine Sulfate Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Purity
      • 6.1.2.1.Less than 98%
      • 6.1.2.2.98% to 99%
      • 6.1.2.3.Above 99%
    • 6.1.3.By Mode of Administration
      • 6.1.3.1.Intravenous Injections
      • 6.1.3.2.Nasal Spray
    • 6.1.4.By Disease Indication
      • 6.1.4.1.Spinal Anesthesia-Induced Hypotension
      • 6.1.4.2.Nasal Congestion
      • 6.1.4.3.Bronchial Asthma
      • 6.1.4.4.Others
    • 6.1.5.United States*
      • 6.1.5.1.Market Size & Forecast
        • 6.1.5.1.1.By Value
        • 6.1.5.1.2.By Volume
      • 6.1.5.2.By Purity
        • 6.1.5.2.1.Less than 98%
        • 6.1.5.2.2.98% to 99%
        • 6.1.5.2.3.Above 99%
      • 6.1.5.3.By Mode of Administration
        • 6.1.5.3.1.Intravenous Injections
        • 6.1.5.3.2.Nasal Spray
      • 6.1.5.4.By Disease Indication
        • 6.1.5.4.1.Spinal Anesthesia-Induced Hypotension
        • 6.1.5.4.2.Nasal Congestion
        • 6.1.5.4.3.Bronchial Asthma
        • 6.1.5.4.4.Others
    • 6.1.6.Canada
    • 6.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Purity
  • 8.2.By Mode of Administration
  • 8.3.By Disease Indication
  • 8.4.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Supply Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.Spectrum Chemical Mfg. Corp. (Spectrum Laboratory Products, Inc.)
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.Taj Pharmaceutical Limited
  • 14.3.Sigma- Aldrich (Merck KGaA)
  • 14.4.Biosynth
  • 14.5.Midas Pharma
  • 14.6.Malladi Drugs & Pharmaceuticals Ltd.
  • 14.7.Embio Limited
  • 14.8.Siegfried Holding AG
  • 14.9.Nortec Quimica S.A.
  • 14.10.Cymit Quimica S.L.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 2.Global Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 3.Global Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 4.Global Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 5.Global Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 6.Global Ephedrine Sulfate Market Share (%), By Region, 2017-2031F
  • Figure 7.North America Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 8.North America Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 9.North America Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 10.North America Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 11.North America Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 12.North America Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
  • Figure 13.United States Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 14.United States Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 15.United States Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 16.United States Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 17.United States Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 18.Canada Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 19.Canada Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 20.Canada Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 21.Canada Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 22.Canada Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 23.Mexico Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 24.Mexico Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 25.Mexico Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 26.Mexico Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 27.Mexico Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 28.Europe Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 29.Europe Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 30.Europe Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 31.Europe Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 32.Europe Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 33.Europe Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
  • Figure 34.Germany Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 35.Germany Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 36.Germany Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 37.Germany Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 38.Germany Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 39.France Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 40.France Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 41.France Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 42.France Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 43.France Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 44.Italy Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 45.Italy Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 46.Italy Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 47.Italy Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 48.Italy Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 49.United Kingdom Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 50.United Kingdom Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 51.United Kingdom Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 52.United Kingdom Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 53.United Kingdom Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 54.Russia Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 55.Russia Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 56.Russia Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 57.Russia Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 58.Russia Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 59.Netherlands Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 60.Netherlands Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 61.Netherlands Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 62.Netherlands Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 63.Netherlands Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 64.Spain Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 65.Spain Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 66.Spain Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 67.Spain Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 68.Spain Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 69.Turkey Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 70.Turkey Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 71.Turkey Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 72.Turkey Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 73.Turkey Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 74.Poland Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 75.Poland Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 76.Poland Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 77.Poland Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 78.Poland Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 79.South America Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 80.South America Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 81.South America Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 82.South America Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 83.South America Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 84.South America Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
  • Figure 85.Brazil Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 86.Brazil Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 87.Brazil Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 88.Brazil Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 89.Brazil Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 90.Argentina Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 91.Argentina Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 92.Argentina Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 93.Argentina Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 94.Argentina Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 95.Asia-Pacific Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 96.Asia-Pacific Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 97.Asia-Pacific Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 98.Asia-Pacific Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 99.Asia-Pacific Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 100.Asia-Pacific Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
  • Figure 101.India Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 102.India Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 103.India Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 104.India Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 105.India Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 106.China Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 107.China Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 108.China Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 109.China Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 110.China Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 111.Japan Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 112.Japan Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 113.Japan Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 114.Japan Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 115.Japan Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 116.Australia Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 117.Australia Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 118.Australia Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 119.Australia Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 120.Australia Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 121.Vietnam Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 122.Vietnam Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 123.Vietnam Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 124.Vietnam Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 125.Vietnam Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 126.South Korea Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 127.South Korea Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 128.South Korea Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 129.South Korea Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 130.South Korea Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 131.Indonesia Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 132.Indonesia Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 133.Indonesia Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 134.Indonesia Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 135.Indonesia Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 136.Philippines Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 137.Philippines Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 138.Philippines Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 139.Philippines Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 140.Philippines Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 141.Middle East & Africa Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 142.Middle East & Africa Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 143.Middle East & Africa Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 144.Middle East & Africa Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 145.Middle East & Africa Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 146.Middle East & Africa Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
  • Figure 147.Saudi Arabia Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 148.Saudi Arabia Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 149.Saudi Arabia Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 150.Saudi Arabia Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 151.Saudi Arabia Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 152.UAE Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 153.UAE Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 154.UAE Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 155.UAE Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 156.UAE Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 157.South Africa Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
  • Figure 158.South Africa Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
  • Figure 159.South Africa Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
  • Figure 160.South Africa Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
  • Figure 161.South Africa Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
  • Figure 162.By Purity Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 163.By Mode of Administration Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 164.By Disease Indication Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 165.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023